Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

IPS Extends Global Reach with Local Brazil Office

Published: Friday, November 09, 2012
Last Updated: Friday, November 09, 2012
Bookmark and Share
IPS-Integração de Projetos e Serviços accommodates clients growing needs in South America.

IPS-Integrated Project Services has announced the launch of IPS Integração de Projetos e Serviços.

With a new office in Brazil, IPS enhances its ability to support and accommodate clients growing needs in emerging markets.

IPS-Integração de Projetos e Serviços will operate under the leadership of Francisco Paula Santos, a native of Brazil and an industry executive with extensive experience managing and leading global efforts for major pharmaceutical companies such as Bristol-Myers Squibb (BMS) and Wyeth.

At BMS, he was Vice President of Latin America Technical Operations where he oversaw all operations for Latin Americas.

As General Manger of IPS-Integração de Projetos e Serviços, Mr. Santos will be responsible for the strategic direction and growth of the office in Brazil.

“With a rapidly growing economy, and as the world’s fifth largest country, the Brazil market offers a great deal of opportunity for IPS and our clients,” said Dave Goswami, PE, Chief Executive Officer and Managing Director, IPS.

Goswami continued, “As more and more of our multinational clients are opening facilities in Brazil, as well the local companies intend to construct and/or upgrade its facilities, it is essential for IPS to have a local presence. Our Brazil office will enable us to continue to provide clients with innovative and cost effective business solutions and our superior technical expertise that they have come to expect from our IPS team and brand.”

“Our venture into this region supports our long-term growth strategy and our mission and vision of being the knowledge leaders of choice by helping our clients succeed,” continued Goswami.

“We are excited to have a local presence in Brazil and are confident that Francisco and our local team will deliver the IPS brand in this region and will be able to help our clients maximize their growth potential globally.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos